GlassScriptPhysician profile
Whitney Jackson Moore
NPI 1427560531
$655.90
in general payments reported to CMS, 2019-2025
13 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $97.16 · 2022: $173 · 2023: $72.70 · 2024: $149 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $192.99 | 2022-2023 | |
| Lilly USA, LLC | $90.30 | 2021-2024 | Zepbound, Mounjaro |
| Phathom Pharmaceuticals, INC. | $85.82 | 2024-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.14 | 2025 | Jardiance |
| Jazz Pharmaceuticals INC. | $44.42 | 2024 | |
| Pfizer INC. | $35.20 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $35.01 | 2021-2023 | Breztri |
| Janssen Pharmaceuticals, INC | $23.86 | 2021 | |
| Seqirus USA INC | $21.60 | 2025 | Flucelvax, Fluad |
| Otsuka America Pharmaceutical, INC. | $20.20 | 2024 | Rexulti |
| Alexion Pharmaceuticals, INC. | $14.51 | 2022 | |
| Ardelyx, INC. | $14.46 | 2024 | Ibsrela |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.39 | 2025 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.